Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213–60.

Article  PubMed  Google Scholar 

Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J. 2020;84:831–65.

Article  PubMed  Google Scholar 

Akita K, Inohara T, Yamaji K, Kohsaka S, Numasawa Y, Ishii H, et al. Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan. Eur Heart J Cardiovasc Pharmacother. 2020;6:231–8.

Article  PubMed  Google Scholar 

Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, et al. Prediction of thrombotic and bleeding events after percutaneous coronary intervention: credo-kyoto thrombotic and bleeding risk scores. J Am Heart Assoc. 2018;7:e008708.

Article  PubMed  PubMed Central  Google Scholar 

Kaikita K, Yasuda S, Akao M, Ako J, Matoba T, Nakamura M, et al. Bleeding and subsequent cardiovascular events and death in atrial fibrillation with stable coronary artery disease: insights from the AFIRE trial. Circ Cardiovasc Interv. 2021;14:e010476.

Article  CAS  PubMed  Google Scholar 

Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, et al. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014;11:597–606.

Article  PubMed  Google Scholar 

Nakamura M, Iizuka T, Sagawa K, Abe K, Chikada S, Arai M. Prasugrel for Japanese patients with acute coronary syndrome in short-term clinical practice (PRASFIT-Practice I): a postmarketing observational study. Cardiovasc Interv Ther. 2018;33:135–45.

Article  CAS  PubMed  Google Scholar 

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, et al. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: The STOPDAPT-2 randomized clinical trial. JAMA. 2019;321:2414–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ueki Y, Bar S, Losdat S, Otsuka T, Zanchin C, Zanchin T, et al. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores. EuroIntervention. 2020;16:371–9.

Article  PubMed  Google Scholar 

Sawano M, Yamaji K, Kohsaka S, Inohara T, Numasawa Y, Ando H, et al. Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry. Cardiovasc Interv Ther. 2020;35:218–26.

Article  PubMed  PubMed Central  Google Scholar 

Japan nephrology s. [Special issue: Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012]. Nihon Jinzo Gakkai Shi. 2012;54:1034-191.

Inohara T, Kohsaka S, Yamaji K, Ishii H, Amano T, Uemura S, et al. Risk stratification model for in-hospital death in patients undergoing percutaneous coronary intervention: a nationwide retrospective cohort study in Japan. BMJ Open. 2019;9:e026683.

Article  PubMed  PubMed Central  Google Scholar 

Ueki Y, Otsuka T, Bar S, Koskinas KC, Heg D, Haner J, et al. Frequency and outcomes of periprocedural MI in patients with chronic coronary syndromes undergoing PCI. J Am Coll Cardiol. 2022;79:513–26.

Article  PubMed  Google Scholar 

Ndrepepa G, Schuster T, Hadamitzky M, Byrne RA, Mehilli J, Neumann FJ, et al. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2012;125:1424–31.

Article  PubMed  Google Scholar 

Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, et al. Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS. J Am Coll Cardiol. 2016;67:2224–34.

Article  PubMed  Google Scholar 

Valgimigli M, Gagnor A, Calabro P, Frigoli E, Leonardi S, Zaro T, et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385:2465–76.

Article  PubMed  Google Scholar 

Doyle BJ, Ting HH, Bell MR, Lennon RJ, Mathew V, Singh M, et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv. 2008;1:202–9.

Article  PubMed  Google Scholar 

Urban P, Gregson J, Owen R, Mehran R, Windecker S, Valgimigli M, et al. Assessing the risks of bleeding vs thrombotic events in patients at high bleeding risk after coronary stent implantation: the ARC-High bleeding risk trade-off model. JAMA Cardiol. 2021;6:410–9.

Article  PubMed  PubMed Central  Google Scholar 

Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, et al. Ticagrelor with or without aspirin in high-risk patients after PCI. N Engl J Med. 2019;381:2032–42.

Article  CAS  PubMed  Google Scholar 

Valgimigli M, Frigoli E, Heg D, Tijssen J, Juni P, Vranckx P, et al. Dual antiplatelet therapy after PCI in patients at high bleeding risk. N Engl J Med. 2021;385:1643–55.

Article  CAS  PubMed  Google Scholar 

Costa F, Van Klaveren D, James S, Heg D, Räber L, Feres F, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389:1025–34.

Article  PubMed  Google Scholar 

Costa F, Van Klaveren D, Feres F, James S, Räber L, Pilgrim T, et al. Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting. J Am Coll Cardiol. 2019;73:741–54.

Article  PubMed  Google Scholar 

Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Nishikawa R, et al. Clopidogrel vs aspirin monotherapy beyond 1 year after percutaneous coronary intervention. J Am Coll Cardiol. 2024;83:17–31.

Article  CAS  PubMed  Google Scholar 

Kang J, Park KW, Lee H, Hwang D, Yang HM, Rha SW, et al. Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study. Circulation. 2023;147:108–17.

Article  CAS  PubMed  Google Scholar 

Mach F, Koskinas KC, van Roeters Lennep JE, Tokgozoglu L, Badimon L, Baigent C, et al. 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46:4359–78.

Article  CAS  PubMed  Google Scholar 

Zaman S, Wasfy JH, Kapil V, Ziaeian B, Parsonage WA, Sriswasdi S, et al. The Lancet commission on rethinking coronary artery disease: moving from ischaemia to atheroma. Lancet. 2025;405:1264–312.

Article  PubMed  PubMed Central  Google Scholar 

Minami Y, Ako J, Tsujita K, Yokoi H, Ikari Y, Morino Y, et al. Drug intervention as an emerging concept for secondary prevention in patients with coronary disease. Cardiovasc Interv Ther. 2024;39:223–33.

Article  CAS  PubMed  Google Scholar 

Piccolo R, Oliva A, Avvedimento M, Franzone A, Windecker S, Valgimigli M, et al. Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis. EuroIntervention. 2021;17:550–60.

Article  PubMed  PubMed Central  Google Scholar 

Natsuaki M, Morimoto T, Shiomi H, Ehara N, Taniguchi R, Tamura T, et al. Application of the modified high bleeding risk criteria for Japanese patients in an all-comers registry of percutaneous coronary intervention-from the CREDO-Kyoto registry cohort-3-. Circ J. 2021;85:769–81.

Article  CAS  PubMed  Google Scholar